About this policy
CMS National Coverage Determination | ncd_id=336 | manual_section=220.6.19 | coverage_level_code=2 | national_coverage_type=True | under_review=True | lab_ncd=False
Coverage indications
B. Nationally Covered Indications The confirmatory analyses were not published during the 24-month time period. Therefore, effective December 15, 2017, CMS determines that there are no nationally covered indications for PET NaF-18. C. Nationally Non-Covered Indications Effective December 15, 2017, CMS determines that PET NaF-18 PET is nationally non-covered. D. Other Other PET radiopharmaceutical tracers for cancer can be covered at local Medicare Administrative Contractor discretion when used according to their FDA-approved indication(s). (This NCD last reviewed December 2017.)
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.